2022 ICC Recategorization Facilitates Risk Stratification of Myelodysplastic Syndrome

THURSDAY, Jan. 19, 2023 -- Clinical characteristics, outcomes, and genetic features vary among different myelodysplastic syndrome (MDS) subtypes categorized using the 2022 International Consensus Classification (ICC), according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news